Skip to content

Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

Neuromodulation Using Low-intensity Focused Ultrasound for Potential Treatment for Medically Refractory Temporal Lobe Epilepsy

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07353918
Enrollment
6
Registered
2026-01-21
Start date
2025-10-13
Completion date
2028-05-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy (Treatment Refractory), Epilepsy Comorbidities

Keywords

LIFU, Neuromodulation, Seizure

Brief summary

This study is an invite only study looking at the effects of Low-Intensity Focused Ultrasound (LIFU) on epilepsy patients with implanted electrodes under the care of Dr. Shah.

Detailed description

This project will explore the use of Low-Intensity Focused Ultrasound (LIFU) as a non-invasive method to reduce seizures and potentially enhance cognitive functions in epilepsy patients. LIFU can target specific deep brain areas without surgery, offering an alternative to invasive procedures. The study focuses on patients who have an implanted Responsive Neurostimulation System (RNS). LIFU will be used to stimulate the entorhinal cortex, a brain region involved in both seizure activity and memory formation. Investigators are targeting the perforant pathway from EC to hippocampus, which primarily relies of layers II and III of EC. Therefore, this targeting will ensure that layers II and III of EC are within the beam profile of LIFU. During study visits, participant will receive non-invasive ultrasound stimulation in their brains. Investigators will measure seizure frequency and epileptic activity using the implanted RNS system to assess LIFU's effects for epilepsy. Neuropsychological and memory tests will be conducted before and after LIFU application to detect changes in cognitive functions. Investigators will compare results before and after stimulation to determine LIFU's effectiveness in reducing seizures and potentially improving memory or other cognitive functions.

Interventions

focused ultrasound transducer.

DEVICESham

Sham application of LIFU - energy blocked. Targeted to the same target as intervention.

Sponsors

Carilion Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will not know which visit is real and which is sham. Both appear identical to the participant. The sham is performed by blocking the energy applied to the skull during LIFU. Analysis will be done prior to unblinding researchers. Only researchers interacting with the participant will know visit order.

Intervention model description

This study is a within subject cross-over design with 1 visit with a real LIFU application, and 1 visit with a sham LIFU application. Order will be randomized.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of medically refractory focal epilepsy of mesial temporal onset * RNS system implantation in the hippocampus * Prior MRI and CT of the head * Able to consent for themselves * Internet access

Exclusion criteria

* TBI (ongoing, or in the prior 6 months) * Currently pregnant or breastfeeding * Progressive diseases - such as autoimmune epilepsies or diagnosis of a progressive neurological disorder * Status epilepticus within one year of study start * History of suicidal ideation or attempts in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Seizure Frequency6 months past their final research study visitUtilizing the implanted RNS system patient seizure frequency will be monitored over time following both real and sham intervention.

Secondary

MeasureTime frameDescription
Report of Symptoms QuestionnairesWithin session, approximately over a 3 hour period.To evaluate the safety profile and tolerability of LIFU delivery, measured by a series questionnaires pre and post LIFU application evaluating symptoms and side-effects. Participants are asked to report any existing (pre) \& new (post) symptoms
Memory EncodingWithin session, over approximately 3 hours.To evaluate the cognitive effects of LIFU delivery on memory, participants will be assessed for correct vs incorrect encoding (face/name pair shown, \& then queried after a distractor task). % correct will be assessed.
Working Memory TaskWithin session, over approximately 3 hours.To evaluate the cognitive effects of LIFU delivery on working memory, participants will be assessed for correct vs incorrect encoding (given a list of objects, asked to recall in smallest to largest order). % correct will be assessed.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAashit Shah, MD

Carilion Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026